Piramal Pharma Limited (PPLPHARMA.NS)
INR 219.87
(-1.68%)
INR 219.87
(-1.68%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 24.83 Billion INR | -28.74% |
| 2022 | 34.85 Billion INR | 665.77% |
| 2021 | 4.55 Billion INR | 6075.85% |
| 2020 | 73.7 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 15.35 Billion INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 24.83 Billion INR | -28.74% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 24.83 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 29.56 Billion INR | 0.0% |
| 2022 Q2 | 34.15 Billion INR | 0.0% |
| 2022 FY | 34.85 Billion INR | 665.77% |
| 2022 Q4 | 34.85 Billion INR | 0.56% |
| 2022 Q3 | 34.66 Billion INR | 1.48% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q4 | 4.55 Billion INR | 0.0% |
| 2021 FY | 4.55 Billion INR | 6075.85% |
| 2020 FY | 73.7 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Biocon Limited | 129.32 Billion INR | 80.794% |
| Blue Jet Healthcare Limited | 3.79 Million INR | -655243.008% |
| Concord Biotech Limited | 18.87 Million INR | -131524.271% |
| Dishman Carbogen Amcis Limited | 2.45 Billion INR | -911.258% |
| Jubilant Ingrevia Limited | 4.25 Billion INR | -483.629% |
| Lyka Labs Limited | 429.06 Million INR | -5688.723% |
| Panacea Biotec Limited | 209.9 Million INR | -11733.016% |
| SMS Lifesciences India Limited | 331.45 Million INR | -7393.589% |
| Supriya Lifescience Limited | 50.2 Million INR | -49377.092% |
| Syngene International Limited | 1 Billion INR | -2383.75% |
| TAKE Solutions Limited | 7.5 Million INR | -331066.667% |
| Zota Health Care Limited | 631.64 Million INR | -3832.212% |